What stage does Asclepius Life Sciences Fund, LP invest at?

Asclepius Life Sciences Fund, LP invests at the Seed, Series A, Series B stages.

What sectors does Asclepius Life Sciences Fund, LP focus on?

Asclepius Life Sciences Fund, LP focuses on AgTech, Biotech, Digital Health, Healthtech, Medical Devices.

Where is Asclepius Life Sciences Fund, LP located?

Asclepius Life Sciences Fund, LP is headquartered in New York, US.

Asclepius Life Sciences Fund, LP

Venture capital

New York · Seed–Series B · 4 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Asclepius Life Sciences Fund, LP

1 people in our graph share verified history with the Asclepius Life Sciences Fund, LP team — schools, employers, funds. One of them is your warm intro.

Marissa Fayerunlockedknows Steve Mackey · together at Asclepius Life Sciences Fund, LP

✨ Fox Verdict

Investment thesis

Asclepius invests exclusively in private-market life sciences companies, spanning healthcare, pharmaceuticals, agriculture, personal care, biosciences and biotechnology. The fund seeks to exploit market inefficiencies by combining operational expertise, deep scientific insight and rigorous financial analysis, drawing on a leadership team with extensive experience across investment, biopharmaceuticals, life sciences and healthcare management.

Invests inAgTech Biotech Digital Health Healthtech Medical Devices New York United States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series B

New York, New York, US

Instruments

Equity

Founded

2016

Team · 4 people

from the firm's website & public directories

Dr. Steven Gerst· Co-Founder & Principal

Gerst focuses on biopharma and medical technology and holds Series 7 and Series 65 securities licenses. A Columbia-trained M.D. with additional degrees from Emory and Columbia, he has held leadership roles at Columbia/HCA, Crawford & Company and Premier, and works on connected health projects with major technology and healthcare firms.

Steve Glover· Co-Founder & Managing Principal

Glover has 30+ years of experience in biopharmaceuticals and life sciences, with a background spanning turnarounds, business strategy, corporate development, and commercialization across 25+ transactions worth over $10 billion. He is co-founder, President and CEO of ZyVersa Therapeutics and previously co-founded Coherus BioSciences.

s•••@asclepiuslifesciences.comreveal

Steven Gerst· Co-Founder & Principal

Dr. Gerst focuses on biopharma and medical technology and holds Series 7 and Series 65 securities licenses. A physician trained at Columbia with multiple business degrees, he has held senior roles at PwC, Columbia/HCA, Crawford & Company and Premier, and works on connected health platforms.

s•••@asclepiuslifesciences.comreveal

Steve Mackey· Managing Director, Asclepius Master Fund, LTD.

Mackey has over 30 years in global financial services and represents the Fund globally. He is CEO and founder of MLG Capital in The Bahamas and previously held executive roles at RBC, EFG International and Credit Suisse across multiple countries.

Frequently asked questions

What stage does Asclepius Life Sciences Fund, LP invest at?: Asclepius Life Sciences Fund, LP invests at the Seed, Series A, Series B stages.
What sectors does Asclepius Life Sciences Fund, LP focus on?: Asclepius Life Sciences Fund, LP focuses on AgTech, Biotech, Digital Health, Healthtech, Medical Devices.
Where is Asclepius Life Sciences Fund, LP located?: Asclepius Life Sciences Fund, LP is headquartered in New York, US.

Images

Similar investors

Voima Ventures

Voima Ventures is a deep tech venture capital firm that backs founders building global solutions across people, planet, and industry, from technology spin-offs to scaling companies.

$216K – $3.2M

Seventure Partners

Seventure Partners is a European venture capital firm, founded in 1997 and a subsidiary of Natixis Investment Managers, investing in digital technologies and life sciences companies with strong growth potential.

Sofinnova Partners

Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.

$540K – $27M

GO Capital

GO Capital is a French investment firm founded in 2003 that backs high-growth companies in digital, health, and industry-of-the-future sectors, with a focus on sustainable innovation across regional territories.

$162K – $2.2M

VTC Ventures

VTC Ventures is an early-stage venture fund managed by Middleland Capital and backed by strategic LPs including Virginia Tech, the Fralin Biomedical Research Institute, and Carilion Clinic. It invests in healthcare, deep tech/defense/AI, and food & agriculture, offering founders access to clinical, research, and commercialization resources.

$100K – $5M